Copay help by condition · Heart and circulation · read 2026-11-08
Hypertrophic cardiomyopathy: which charitable copay funds are open
1 fund for Hypertrophic cardiomyopathy says it is open right now, of the 1 we hold (read 2026-11-08).
Open: Hypertrophic cardiomyopathy from TotalAssist (Patient Advocate Foundation copay funds). Eligibility is each fund's own rule.
If you have Medicare Part D: CMS prints the annual out-of-pocket threshold as $2,400 in 2027 ($2,100 in 2026) (Table V-2 of its CY 2027 announcement). It is a benefit parameter and applies to covered drugs under plan rules. What changes on January 1.
Swipe to read across
A copy for a patient, a clinic or a pharmacist, with each source and the date we read it.
Every fund we hold for Hypertrophic cardiomyopathy
- OpenHypertrophic cardiomyopathy
TotalAssist (Patient Advocate Foundation copay funds) ·
Award level: $7,200Insurance supported: Any health insurance
The page lists the fund as Open. Source page
Drugs whose FDA label names Hypertrophic cardiomyopathy
1 drug. Each row quotes the sentence of the drug's FDA label (Indications and Usage, openFDA) that names the condition. A label naming a condition is not a statement that the drug is approved, effective or covered for you. Dashes in quotes are shown as hyphens. Of these, 1 has a program (in our assistance finder or on the program's own page) and 0 have a Medicare negotiated price in the CMS file; an empty cell says we found nothing in our data, not that nothing exists.
| Drug | What the FDA label says | Manufacturer program | Medicare negotiated price |
|---|---|---|---|
| Camzyos Mavacamten Every route for this drug | CAMZYOS ® is indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms. Label on openFDA, read 2026-11-10 | Bristol Myers Squibb Patient Assistance Foundation (program page) additional REMS requirements | not in the CMS negotiated-price file |
Related conditions
No broader or more specific condition page for this one.
Group: Heart and circulation. All conditions: the condition index. Fund board for every condition: charitable copay fund status.
What changed
First read on 2026-11-08. We keep each read with its date, so a fund reopening or closing will show here as a change. Until we have a second read there is nothing to compare, and we do not guess. The read date of every source is on the changes page.
This page as data
The same facts as JSON, each fund with its source URL and read date: hypertrophic-cardiomyopathy.json. Edition 2026-11, root 006ab9a329709cbe. See the licence page.
Questions
Is there an open charitable copay fund for Hypertrophic cardiomyopathy?
As read on 2026-11-08, 1 of the 1 funds we hold for Hypertrophic cardiomyopathy say they are open: Hypertrophic cardiomyopathy from TotalAssist (Patient Advocate Foundation copay funds). Funds open and close, so check the source page before you apply.
Which organizations run funds for Hypertrophic cardiomyopathy?
TotalAssist (Patient Advocate Foundation copay funds). Each fund row on this page links to the organization's own page.
Does an open fund mean I qualify?
No. A status says whether a fund is taking applications. Eligibility, award level and which insurance it supports are each fund's own rules; where the page states them they are shown on the fund.
How current is this page?
Statuses are what each fund's own page said on the date we read it (2026-11-08). We do not promise a fund is still in that state today.